Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Cost-effectiveness of cardiovascular risk management by practice nurses in primary care

Authors: Ans H Tiessen, Karin M Vermeulen, Jan Broer, Andries J Smit, Klaas van der Meer

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Cardiovascular disease (CVD) is largely preventable and prevention expenditures are relatively low. The randomised controlled SPRING-trial (SPRING-RCT) shows that cardiovascular risk management by practice nurses in general practice with and without self-monitoring both decreases cardiovascular risk, with no additional effect of self-monitoring. For considering future approaches of cardiovascular risk reduction, cost effectiveness analyses of regular care and additional self-monitoring are performed from a societal perspective on data from the SPRING-RCT.

Methods

Direct medical and productivity costs are analysed alongside the SPRING-RCT, studying 179 participants (men aged 50–75 years, women aged 55–75 years), with an elevated cardiovascular risk, in 20 general practices in the Netherlands. Standard cardiovascular treatment according to Dutch guidelines is compared with additional counselling based on self-monitoring at home (pedometer, weighing scale and/ or blood pressure device) both by trained practice nurses. Cost-effectiveness is evaluated for both treatment groups and patient categories (age, sex, education).

Results

Costs are €98 and €187 per percentage decrease in 10-year cardiovascular mortality estimation, for the control and intervention group respectively. In both groups lost productivity causes the majority of the costs. The incremental cost-effectiveness ratio is approximately €1100 (95% CI: -5157 to 6150). Self-monitoring may be cost effective for females and higher educated participants, however confidence intervals are wide.

Conclusions

In this study population, regular treatment is more cost effective than counselling based on self-monitoring, with the majority of costs caused by lost productivity.

Trial registration

Trialregister.nl identifier: NTR2188
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: W 74 2008GL. The global burden of disease: 2004 update. 2008, Geneva, Switzerland World Health Organization: W 74 2008GL. The global burden of disease: 2004 update. 2008, Geneva, Switzerland
2.
go back to reference Fifth Joint Task Force of the European Society of Cardiology, European Association of Echocardiography, European Association of Percutaneous Cardiovascular Interventions, European Heart Rhythm Association, Heart Failure Association, European Association for Cardiovascular Prevention & Rehabilitation, European Atherosclerosis Society, International Society of Behavioural Medicine, European Stroke Organisation, European Society of Hypertension, European Association for the Study of Diabetes, European Society of General Practice/Family Medicine, International Diabetes Federation Europe, European Heart Network: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012, 19 (4): 585-667.CrossRef Fifth Joint Task Force of the European Society of Cardiology, European Association of Echocardiography, European Association of Percutaneous Cardiovascular Interventions, European Heart Rhythm Association, Heart Failure Association, European Association for Cardiovascular Prevention & Rehabilitation, European Atherosclerosis Society, International Society of Behavioural Medicine, European Stroke Organisation, European Society of Hypertension, European Association for the Study of Diabetes, European Society of General Practice/Family Medicine, International Diabetes Federation Europe, European Heart Network: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012, 19 (4): 585-667.CrossRef
3.
go back to reference de Bekker-Grob EW, van Dulmen S, van den Berg M, Verheij RA, Slobbe LC: Primary prevention of cardiovascular diseases: a cost study in family practices. BMC Fam Pract. 2011, 12: 69-10.1186/1471-2296-12-69.CrossRefPubMedPubMedCentral de Bekker-Grob EW, van Dulmen S, van den Berg M, Verheij RA, Slobbe LC: Primary prevention of cardiovascular diseases: a cost study in family practices. BMC Fam Pract. 2011, 12: 69-10.1186/1471-2296-12-69.CrossRefPubMedPubMedCentral
4.
go back to reference Kok L, Engelfriet P, Jacobs-van der Bruggen MA, Hoogenveen RT, Boshuizen HC, Verschuren MW: The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands. Eur J Cardiovasc Prev Rehabil. 2009, 16 (3): 371-376. 10.1097/HJR.0b013e328329497a.CrossRefPubMed Kok L, Engelfriet P, Jacobs-van der Bruggen MA, Hoogenveen RT, Boshuizen HC, Verschuren MW: The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands. Eur J Cardiovasc Prev Rehabil. 2009, 16 (3): 371-376. 10.1097/HJR.0b013e328329497a.CrossRefPubMed
5.
go back to reference Saha S, Gerdtham UG, Johansson P: Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health. 2010, 7 (8): 3150-3195. 10.3390/ijerph7083150.CrossRefPubMedPubMedCentral Saha S, Gerdtham UG, Johansson P: Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health. 2010, 7 (8): 3150-3195. 10.3390/ijerph7083150.CrossRefPubMedPubMedCentral
6.
go back to reference Grover S, Coupal L, Lowensteyn I: Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?. Can J Cardiol. 2008, 24 (12): 891-898. 10.1016/S0828-282X(08)70695-0.CrossRefPubMedPubMedCentral Grover S, Coupal L, Lowensteyn I: Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?. Can J Cardiol. 2008, 24 (12): 891-898. 10.1016/S0828-282X(08)70695-0.CrossRefPubMedPubMedCentral
7.
go back to reference Rasmussen SR, Thomsen JL, Kilsmark J, Hvenegaard A, Engberg M, Lauritzen T, Sogaard J: Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scand J Public Health. 2007, 35 (4): 365-372. 10.1080/14034940701219642.CrossRefPubMed Rasmussen SR, Thomsen JL, Kilsmark J, Hvenegaard A, Engberg M, Lauritzen T, Sogaard J: Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scand J Public Health. 2007, 35 (4): 365-372. 10.1080/14034940701219642.CrossRefPubMed
8.
go back to reference Yosefy C, Ginsberg GM, Dicker D, Viskoper JR, Tulchinsky TH, Leibovitz E, Gavish D: IBPC Investigators: Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program–initial cost utility analysis. Blood Press. 2003, 12 (4): 225-231. 10.1080/08037050310015485.CrossRefPubMed Yosefy C, Ginsberg GM, Dicker D, Viskoper JR, Tulchinsky TH, Leibovitz E, Gavish D: IBPC Investigators: Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program–initial cost utility analysis. Blood Press. 2003, 12 (4): 225-231. 10.1080/08037050310015485.CrossRefPubMed
9.
go back to reference Yosefy C, Dicker D, Viskoper JR, Tulchinsky TH, Ginsberg GM, Leibovitz E, Gavish D: The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prev Med. 2003, 37 (6 Pt 1): 571-576.CrossRefPubMed Yosefy C, Dicker D, Viskoper JR, Tulchinsky TH, Ginsberg GM, Leibovitz E, Gavish D: The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prev Med. 2003, 37 (6 Pt 1): 571-576.CrossRefPubMed
10.
go back to reference Yosefy C, Ginsberg G, Viskoper R, Dicker D, Gavish D: Cost-utility analysis of a national project to reduce hypertension in Israel. Cost Eff Resour Alloc. 2007, 5: 16-10.1186/1478-7547-5-16.CrossRefPubMedPubMedCentral Yosefy C, Ginsberg G, Viskoper R, Dicker D, Gavish D: Cost-utility analysis of a national project to reduce hypertension in Israel. Cost Eff Resour Alloc. 2007, 5: 16-10.1186/1478-7547-5-16.CrossRefPubMedPubMedCentral
11.
go back to reference Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P, Graham-Clarke P, Walker S, Shaw J: The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health Policy. 1997, 41 (2): 105-119. 10.1016/S0168-8510(97)00015-8.CrossRefPubMed Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P, Graham-Clarke P, Walker S, Shaw J: The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health Policy. 1997, 41 (2): 105-119. 10.1016/S0168-8510(97)00015-8.CrossRefPubMed
12.
go back to reference Langham S, Thorogood M, Normand C, Muir J, Jones L, Fowler G: Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ. 1996, 312 (7041): 1265-1268. 10.1136/bmj.312.7041.1265.CrossRefPubMedPubMedCentral Langham S, Thorogood M, Normand C, Muir J, Jones L, Fowler G: Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ. 1996, 312 (7041): 1265-1268. 10.1136/bmj.312.7041.1265.CrossRefPubMedPubMedCentral
13.
go back to reference Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, Wood D: Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ. 1996, 312 (7041): 1269-1273. 10.1136/bmj.312.7041.1269.CrossRefPubMedPubMedCentral Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, Wood D: Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ. 1996, 312 (7041): 1269-1273. 10.1136/bmj.312.7041.1269.CrossRefPubMedPubMedCentral
14.
go back to reference Wonderling D, Langham S, Buxton M, Normand C, McDermott C: What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses. BMJ. 1996, 312 (7041): 1274-1278. 10.1136/bmj.312.7041.1274.CrossRefPubMedPubMedCentral Wonderling D, Langham S, Buxton M, Normand C, McDermott C: What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses. BMJ. 1996, 312 (7041): 1274-1278. 10.1136/bmj.312.7041.1274.CrossRefPubMedPubMedCentral
15.
go back to reference Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24 (0195–668; 11): 987-1003.CrossRefPubMed Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24 (0195–668; 11): 987-1003.CrossRefPubMed
16.
go back to reference Tiessen AH, Smit AJ, Broer J, Groenier KH, van der Meer K: Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care. BMC Fam Pract. 2012, 13 (1): 90-10.1186/1471-2296-13-90.CrossRefPubMedPubMedCentral Tiessen AH, Smit AJ, Broer J, Groenier KH, van der Meer K: Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care. BMC Fam Pract. 2012, 13 (1): 90-10.1186/1471-2296-13-90.CrossRefPubMedPubMedCentral
17.
go back to reference Stalman WAB, Scheltens T, Burgers JS, Hukkelhoven CWPM, Smorenburg SM, Banga JD, Dippel DJW, van Dis SJ, Grobbee DE, Hoes AW, van Hout BA, Jukema JW, Kitslaar PJEHM, Kromhout D, Peters RJ, Simoons ML, Smulders YM, Stehouwer CDA, Thomas S, Walma EP, Wiersma T: NHG standard cardiovasculair risicomanagement. [Practice guideline Cardiovascular risk management from Dutch General Practitioners Society; Dutch]. 2006, Utrecht, the Netherlands Stalman WAB, Scheltens T, Burgers JS, Hukkelhoven CWPM, Smorenburg SM, Banga JD, Dippel DJW, van Dis SJ, Grobbee DE, Hoes AW, van Hout BA, Jukema JW, Kitslaar PJEHM, Kromhout D, Peters RJ, Simoons ML, Smulders YM, Stehouwer CDA, Thomas S, Walma EP, Wiersma T: NHG standard cardiovasculair risicomanagement. [Practice guideline Cardiovascular risk management from Dutch General Practitioners Society; Dutch]. 2006, Utrecht, the Netherlands
18.
go back to reference Hakkaart-van Roijen L, Tan SS, Bouwmans CAM: Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen. Geactualiseerde versie 2010. [Manual for cost analysis in health care; Dutch]. 2011, Rotterdam, the Netherlands Hakkaart-van Roijen L, Tan SS, Bouwmans CAM: Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen. Geactualiseerde versie 2010. [Manual for cost analysis in health care; Dutch]. 2011, Rotterdam, the Netherlands
19.
go back to reference Black WC: The CE plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990, 10 (3): 212-214. 10.1177/0272989X9001000308.CrossRefPubMed Black WC: The CE plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990, 10 (3): 212-214. 10.1177/0272989X9001000308.CrossRefPubMed
20.
go back to reference Fenwick E, O’Brien BJ, Briggs A: Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ. 2004, 13 (5): 405-415. 10.1002/hec.903.CrossRefPubMed Fenwick E, O’Brien BJ, Briggs A: Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ. 2004, 13 (5): 405-415. 10.1002/hec.903.CrossRefPubMed
21.
go back to reference Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996, 313 (7052): 275-283. 10.1136/bmj.313.7052.275.CrossRefPubMedPubMedCentral Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996, 313 (7052): 275-283. 10.1136/bmj.313.7052.275.CrossRefPubMedPubMedCentral
22.
go back to reference Weires M, Bermejo JL, Sundquist K, Sundquist J, Hemminki K: Socio-economic status and overall and cause-specific mortality in Sweden. BMC Publ Health. 2008, 8: 340-10.1186/1471-2458-8-340.CrossRef Weires M, Bermejo JL, Sundquist K, Sundquist J, Hemminki K: Socio-economic status and overall and cause-specific mortality in Sweden. BMC Publ Health. 2008, 8: 340-10.1186/1471-2458-8-340.CrossRef
23.
go back to reference Dray-Spira R, Gary TL, Brancati FL: Socioeconomic position and cardiovascular disease in adults with and without diabetes: United States trends, 1997–2005. J Gen Intern Med. 2008, 23 (10): 1634-1641. 10.1007/s11606-008-0727-5.CrossRefPubMedPubMedCentral Dray-Spira R, Gary TL, Brancati FL: Socioeconomic position and cardiovascular disease in adults with and without diabetes: United States trends, 1997–2005. J Gen Intern Med. 2008, 23 (10): 1634-1641. 10.1007/s11606-008-0727-5.CrossRefPubMedPubMedCentral
24.
go back to reference Saurel-Cubizolles MJ, Chastang JF, Menvielle G, Leclerc A, Luce D, EDISC group: Social inequalities in mortality by cause among men and women in France. J Epidemiol Community Health. 2009, 63 (3): 197-202. 10.1136/jech.2008.078923. Saurel-Cubizolles MJ, Chastang JF, Menvielle G, Leclerc A, Luce D, EDISC group: Social inequalities in mortality by cause among men and women in France. J Epidemiol Community Health. 2009, 63 (3): 197-202. 10.1136/jech.2008.078923.
25.
go back to reference McFadden E, Luben R, Wareham N, Bingham S, Khaw KT: Occupational social class, risk factors and cardiovascular disease incidence in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol. 2008, 23 (7): 449-458. 10.1007/s10654-008-9262-2.CrossRefPubMed McFadden E, Luben R, Wareham N, Bingham S, Khaw KT: Occupational social class, risk factors and cardiovascular disease incidence in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol. 2008, 23 (7): 449-458. 10.1007/s10654-008-9262-2.CrossRefPubMed
27.
go back to reference Mackenbach JP, Bos V, Andersen O, Cardano M, Costa G, Harding S, Reid A, Hemstrom O, Valkonen T, Kunst AE: Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol. 2003, 32 (5): 830-837. 10.1093/ije/dyg209.CrossRefPubMed Mackenbach JP, Bos V, Andersen O, Cardano M, Costa G, Harding S, Reid A, Hemstrom O, Valkonen T, Kunst AE: Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol. 2003, 32 (5): 830-837. 10.1093/ije/dyg209.CrossRefPubMed
28.
29.
go back to reference Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986, 111 (2): 383-390. 10.1016/0002-8703(86)90155-9.CrossRefPubMed Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986, 111 (2): 383-390. 10.1016/0002-8703(86)90155-9.CrossRefPubMed
30.
go back to reference Kuller LH: Cardiovascular disease is preventable among women. Expert Rev Cardiovasc Ther. 2010, 8 (2): 175-187. 10.1586/erc.09.125.CrossRefPubMed Kuller LH: Cardiovascular disease is preventable among women. Expert Rev Cardiovasc Ther. 2010, 8 (2): 175-187. 10.1586/erc.09.125.CrossRefPubMed
Metadata
Title
Cost-effectiveness of cardiovascular risk management by practice nurses in primary care
Authors
Ans H Tiessen
Karin M Vermeulen
Jan Broer
Andries J Smit
Klaas van der Meer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-148

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue